Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis Sells 376 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 376 shares of the stock in a transaction on Monday, July 29th. The shares were sold at an average price of $446.60, for a total value of $167,921.60. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,458,979.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Robert Desantis also recently made the following trade(s):

• On Friday, July 26th, Robert Desantis sold 1,413 shares of Intuitive Surgical stock. The stock was sold at an average price of $438.60, for a total value of $619,741.80.
• On Monday, June 10th, Robert Desantis sold 239 shares of Intuitive Surgical stock. The stock was sold at an average price of $416.60, for a total transaction of $99,567.40.
• On Tuesday, May 28th, Robert Desantis sold 584 shares of Intuitive Surgical stock. The shares were sold at an average price of $404.41, for a total value of $236,175.44.
• On Friday, May 10th, Robert Desantis sold 239 shares of Intuitive Surgical stock. The shares were sold at an average price of $385.55, for a total transaction of $92,146.45.
• On Monday, May 13th, Robert Desantis sold 284 shares of Intuitive Surgical stock. The shares were sold at an average price of $389.16, for a total value of $110,521.44.

Intuitive Surgical Stock Down 2.5 %

ISRG stock traded down $10.97 during trading on Tuesday, hitting $432.69. The company had a trading volume of 1,501,661 shares, compared to its average volume of 1,558,536. The stock has a market cap of $153.48 billion, a price-to-earnings ratio of 78.33, a PEG ratio of 4.86 and a beta of 1.39. The firm has a 50-day moving average price of $428.69 and a 200-day moving average price of $399.37. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $468.78.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.24. The business had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter last year, the business earned $1.18 earnings per share. Equities analysts expect that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Baystate Wealth Management LLC lifted its stake in Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares during the period. Creekmur Asset Management LLC grew its holdings in shares of Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares in the last quarter. MCF Advisors LLC increased its position in shares of Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 40 shares during the last quarter. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $26,000. Finally, Able Wealth Management LLC bought a new position in Intuitive Surgical during the fourth quarter worth about $28,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of analyst reports. Barclays increased their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a research note on Friday, July 19th. The Goldman Sachs Group started coverage on shares of Intuitive Surgical in a report on Thursday, May 30th. They issued a “buy” rating and a $500.00 target price on the stock. Robert W. Baird raised their price target on Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Finally, Piper Sandler boosted their price objective on Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Six equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $438.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.